Hypo-Fractionated Radiotherapy for Laryngeal Cancer; is Linac Based Treatment Better?.

Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58(2):71-96.             

Hashibe M, Brennan P, Benhamou S, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 2007;99(10):777-89.          

Muscat JE, Wynder EL. Tobacco, alcohol, asbestos and occupational risk factors for laryngeal cancer. Cancer 1992;69(9):2244-51.     

Ward PH, Hanson DG. Reflux as an etiological factor of carcinoma of the laryngopharynx. Laryngoscope 1988;98(11):1195-9.      

Mlynarek A, Kost K, Gesser R. Radiotherapy versus surgery for early T1-T2 glottic carcinoma. J Otolaryngol 2006;35(6):413-9.         

Brandbo K, Benninger MS. Laser resection of T1a glottic carcinomas: results and postoperative voice quality. Acta Otolaryngol 2004;124(8):976-9.

Mendenhall WM, Morris CG, Amdur RJ, et al. Parameters that predict local control following definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 2003;25(7):535-42.           

Mendenhall WM, Amdur RJ, Morris CG, et al. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 2001;19(20):4029-36.        

Mendenhall WM, Werning JW, Hinerman RW, et al. Management of T1-T2 glottic carcinomas. Cancer 2004;100(9):1786-92.   

O'Sullivan B, Mackillop W, Gilbert R, et al. Controversies in the management of laryngeal cancer: results of an international survey of patterns of care. Radiother Oncol 1994;31(1):23-32.               

Orus C, Leon X, Vega M, et al. Initial treatment of the early stages (I, II) of supraglottic squamous cell carcinoma: partial laryngectomy versus radiotherapy. Eur Arch Otorhinolaryngol 2000;257(9):512-6.              

Yamazaki H, Nishiyama K, Tanaka E, et al. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys 2006;64(1):77-82.               

Mendenhall WM, Parsons JT, Million RR, et al. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications. Int J Radiat Oncol Biol Phys 1988;15(6):1267-73.            

Haugen H, Johansson KA, Mercke C. Hyperfractionated-accelerated or conventionally fractionated radiotherapy for early glottic cancer. Int J Radiat Oncol Biol Phys 2002;52(1):109-19.             

Garden AS, Forster K, Wong PF, et al. Results of radiotherapy for T2N0 glottic carcinoma: does the “2” stand for twice-daily treatment? Int J Radiat Oncol Biol Phys 2003;55(2):322-8.      

Chera BS, Amdur RJ, Morris CG, et al. T1N0 to T2 N0 Squamous cell carcinoma of the glotic larynx treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys 2010;78(2):461-6.                  

Caudell JJ, Schaner PE, Meredith RF, et al. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009;73(2):410-5.             

Dinshaw KA, Sharma V, Agarwal JP, et al. Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/complications. Int J Radiat Oncol Biol Phys 2000;48(3):723-35.               

Mendenhall WM, Riggs CE, Amdur RJ, et al. Altered fractionation and/or adjuvant chemotherapy in definitive irradiation of squamous cell carcinoma of the head and neck. Laryngoscope 2003;113(3):546-51.                        

Woodhouse RJ, Quivey JM, Fu KK, et al. Treatment of carcinoma of the vocal cord. A review of 20 years of experience. Laryngoscope 1981;91(7):1155-62. 

Howell-Burke D, Peters LJ, Goepfert H, et al. T2 glottic cancer. Recurrence, salvage and survival after definitive radiotherapy. Arch Otolaryngol Head Neck 1990;116(7):830-5.                        

Amornmarn R, Prempree T, Viravathana T, et al. A therapeutic approach to early vocal cord carcinoma. Acta Radiol Oncol 1985;24(4):321-5.

Mendenhall WM, Parsons JT, Brant TA, et al. Is elective neck treatment indicated for T2N0 squamous cell carcinoma of the glottic larynx? Radiother Oncol 1989;14(3):199-202.            

Norris AA, Amdur RJ, Morris CG, et al. Hypothyroidism when the thyroid is included only in the low neck field during head and neck radiotherapy. Am J Clin Oncol Cancer Clin Trials 2006;29(5):442-5.              

Epstein BE, Lee DJ, Kashima H, et al. Stage T1 glottic carcinoma: results of radiation therapy or laser excision. Radiology 1990;175(2):567-70.   

Jones AS, Fish B, Fenton JE, et al. The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation? Head Neck 2004;26(2):127-35.            

Loughran S, Calder N, MacGregor FB, et al. Quality of life and voice following endoscopic resection or radiotherapy for early glottic cancer. Clin Otolaryngol 2005;30(1):42-7.                       

Goor KM, Peeters AJ, Mahieu HF, et al. Cordectomy by CO2 laser or radiotherapy for small T1a glottic carcinomas: costs, local control, survival, quality of life, and voice quality. Head Neck 2007;29(2):128-36.          

Le QT, Fu KK, Kroll S, et al. Influence of fraction size, total dose and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys 1997;39(1):115-26.